Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 741 Cr.
- Current Price ₹ 24.7
- High / Low ₹ 33.3 / 18.3
- Stock P/E 10.9
- Book Value ₹ 16.3
- Dividend Yield 0.00 %
- ROCE 11.1 %
- ROE 9.95 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed
Part of BSE Fast Moving Consumer Goods
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 407 | 546 | 536 | 693 | 1,066 | 1,269 | 887 | 1,229 | 1,689 | |
| Sales growth | +34% | -2% | +29% | +54% | +19% | -30% | +39% | +74% | |
| 383 | 526 | 529 | 660 | 1,000 | 1,187 | 811 | 1,143 | 1,558 | |
| Operating Profit | 25 | 20 | 7 | 33 | 66 | 81 | 76 | 86 | 130 |
| OPM % | 6% | 3.7% | 1.3% | 4.7% | 6% | 6% | 9% | 7% | 8% |
| 2 | 8 | 9 | 8 | 9 | 20 | 17 | 29 | 32 | |
| Interest | 4 | 7 | 7 | 8 | 15 | 24 | 34 | 50 | 57 |
| Depreciation | 2 | 3 | 3 | 4 | 4 | 6 | 6 | 7 | 8 |
| Profit before tax | 21 | 19 | 6 | 28 | 55 | 72 | 53 | 59 | 97 |
| Tax % | 25% | 32% | 24% | 30% | 28% | 12% | 21% | 28% | |
| 15 | 13 | 5 | 20 | 39 | 63 | 42 | 42 | 68 | |
| EPS in Rs | 0.90 | 1.79 | 2.09 | 1.39 | 1.41 | 2.27 | |||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 5% |
| TTM: | 74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 75% |
| 3 Years: | 4% |
| TTM: | 58% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 14% |
| Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 | 30 |
| Reserves | 40 | 52 | 57 | 60 | 100 | 335 | 374 | 417 | 460 |
| 81 | 112 | 126 | 162 | 238 | 332 | 418 | 682 | 750 | |
| 70 | 88 | 99 | 84 | 141 | 154 | 152 | 239 | 303 | |
| Total Liabilities | 197 | 257 | 288 | 329 | 500 | 851 | 974 | 1,368 | 1,542 |
| 44 | 46 | 49 | 50 | 52 | 60 | 60 | 88 | 93 | |
| CWIP | 0 | 1 | 0 | 0 | 0 | 0 | 4 | 1 | 5 |
| Investments | 10 | 7 | 12 | 21 | 24 | 34 | 44 | 71 | 82 |
| 143 | 204 | 228 | 259 | 424 | 757 | 867 | 1,208 | 1,363 | |
| Total Assets | 197 | 257 | 288 | 329 | 500 | 851 | 974 | 1,368 | 1,542 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| -22 | -24 | -2 | -15 | -47 | -141 | -132 | -161 | |
| -19 | 2 | -5 | -7 | 1 | -46 | -18 | -43 | |
| 31 | 23 | 8 | 27 | 61 | 258 | 60 | 205 | |
| Net Cash Flow | -10 | 0 | 0 | 5 | 15 | 71 | -91 | 2 |
| Free Cash Flow | -35 | -30 | -7 | -17 | -50 | -154 | -142 | -184 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -69% | -91% | 29% | -40% | -58% | -146% | -170% | -172% |
Ratios
Standalone / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 36 | 18 | 28 | 37 | 41 | 64 | 52 |
| Inventory Days | 94 | 68 | 108 | 88 | 87 | 135 | 274 | 280 |
| Days Payable | 59 | 58 | 59 | 44 | 49 | 43 | 69 | 75 |
| Cash Conversion Cycle | 57 | 47 | 67 | 72 | 75 | 133 | 269 | 256 |
| Working Capital Days | 9 | 10 | 6 | 6 | 10 | 43 | 105 | 63 |
| ROCE % | 15% | 6% | 16% | 23% | 18% | 11% | 11% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Export Revenue Share % |
|
||||||
| Number of Customers Served count |
|||||||
| Fish Meal Installed Capacity MT/year |
|||||||
| Top 10 Customer Concentration % |
|||||||
| Fish Meal Capacity Utilization % |
|||||||
| Fish Meal Production Volume MT |
|||||||
| Fish Oil Production Volume MT |
|||||||
| Insect Protein Waste Processing Capacity TPD |
|||||||
| Insect Protein Wet Waste Processed Tons |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Intimation of Investor Presentation - Q2 & FY-27.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Q2 FY27 revenue rose 108% to ₹5,088.70 Mn; PAT up 158%; Oman facility began production.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Mukka Proteins to invest up to Rs 2.13 crore in SESPL for 46% stake by 31-03-2027.
-
Financial Results For The Quarter And Half Year Ended 30Th September 2026.
- Mukka Proteins approved Q2 FY27 results and ₹2.13 crore investment for 46% stake in SESPL.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
Business Overview:[1]
The company is one of India's largest manufacturers and exporters of fishmeal,
fish oil and fish soluble paste, holding an estimated 25–30% share of India's fishmeal/fish-oil segment by revenue and has evolved into a four-vertical platform spanning
-Fish Protein
-Alternate (Insect) Protein
-Waste Management & Environmental Solutions
-Frozen & Value-Added Marine Products.